HORRY COUNTY, SC (WMBF) – Stage 4 lymphoma is a group of blood cancers that develop in the lymphatic system. One 16-year-old who is battling this disease proves that you can fight through anything you put your mind to.
Horry County Fire Rescue was recently approached by a friend about a 16-year-old junior fireman named Jacob Hawthorne, from the West Hempfield Fire Rescue Station 76 in PA.
According to a post on HCFR, Jacob is battling stage 4 lymphoma, however he is still attending training at the station no matter the situation. Whether he is receiving chemo and blood transfusions, he puts his love for fire service and the community first.
Stage IV Hodgkin lymphoma is characterized by affecting the lymph nodes both above and below the diaphragm, and cancer cells elsewhere in the body, in a lung, or in the liver or bone.
The description of Stage IV NHL differs. When this type of lymphoma spreads to one or more organs other than the lymph nodes and possibly one or more lymph node areas in the body, it is considered Stage IV, a health line article states.
• worsening fatigue
• night sweats
• recurrent high- or low-grade fevers
• weight loss
• bone pain if the bone marrow is involved in Hodgkin lymphoma
• chest pain, shortness of breath, or coughing if lymphomas press on the trachea, or superior vena cava, the large vein that transports blood from the arms and head to the heart
• loss of appetite, abdominal pain or swelling, nausea, vomiting, and constipation if lymphoma causes fluid buildup in the abdomen, enlarges the spleen, or perforates the intestinal wall
Stage IV treatment for DBLCL involves chemotherapy, frequently a regimen called R-CHOP. R-CHOP stands for the chemotherapy, cyclophosphamide, doxorubicin, vincristine, and prednisone, with the addition of rituximab, a monoclonal antibody. Treatment usually lasts about six months.
Treatment for the slow-growing follicular lymphoma often begins with rituximab, with either a single chemotherapy drug such as bendamustine or fludarabine, or a combination of drugs like CHOP. Monoclonal antibodies (ibritumomab and tositumomab) may be used as second-line therapy in advanced follicular lymphoma.